CompetetornamementionedTArevenuegrowth"Science"Service= highestearnerA&Grevenuedecline0-10% onslide/mentioned"Impact""Strategic""DeepDive""Patients""CircleBack"AmolChaubaltakes aquestion"Objective(s)""Protein""Pivot"Rob takesa questionfromMilfordKristenGarveytakes aquestion51-60% onslide/mentionedRob takes aquestionfromsomeoneonlineChemistry= highestearnerAndrewWardtakes aquestion"QC" or"QualityControl"41-50% onslide/mentioned"Chromatography"GuestSpeaker"MissonStatement""DataDriven"WeexceededAOP forthe quarterRob pullssomeoneonstageto speakChristosRosstakes aquestionTechnicalIssues"TouchBase""PainPoint"Clincalrevenuedecline"Empower"*New ProductAnnouncement*Rob iswearinga jacketRob takesa questionfromWilmslowLCDivision =highestearner"Culture"or"CompanyCulture"Industrialrevenuegrowth"Genetic""Customers"Rob takes aquestionfromManchester"Integrate"11-20% onslide/mentionedPharmarevenuegrowth"Synergy"100% onslide/mentioned"R&D""Low-hangingfruit""Stakeholders"Rob iswearing asweater"Shareholders"Rob takesa questionfromWexford"Movetheneedle"31-40% onslide/mentionedWe missedAOP forthe quarterRob iswearinga tie"Metrics"TArevenuedeclineA&GrevenuegrowthDan Rushtakes aquestion71-80% onslide/mentioned21-30% onslide/mentionedClincialrevenuegrowthRob takesa questionfrom NewCastle"Spectacular""Development"CherylKennedytakes aquestionMerger oracquisitionannounced81-90% onslide/mentionedMSDivision =highestearner"Fantastic"said morethan oncein a row91-100% onslide/mentioned"Clinical"61-70% onslide/mentionedIndustrialrevenuedecline"Leverage""Return onInvestment""MassSpectrometry""Logistics""Thinkoutsidethe box""Molecule""Growthmindset"PharmarevenuedeclinedCompetetornamementionedTArevenuegrowth"Science"Service= highestearnerA&Grevenuedecline0-10% onslide/mentioned"Impact""Strategic""DeepDive""Patients""CircleBack"AmolChaubaltakes aquestion"Objective(s)""Protein""Pivot"Rob takesa questionfromMilfordKristenGarveytakes aquestion51-60% onslide/mentionedRob takes aquestionfromsomeoneonlineChemistry= highestearnerAndrewWardtakes aquestion"QC" or"QualityControl"41-50% onslide/mentioned"Chromatography"GuestSpeaker"MissonStatement""DataDriven"WeexceededAOP forthe quarterRob pullssomeoneonstageto speakChristosRosstakes aquestionTechnicalIssues"TouchBase""PainPoint"Clincalrevenuedecline"Empower"*New ProductAnnouncement*Rob iswearinga jacketRob takesa questionfromWilmslowLCDivision =highestearner"Culture"or"CompanyCulture"Industrialrevenuegrowth"Genetic""Customers"Rob takes aquestionfromManchester"Integrate"11-20% onslide/mentionedPharmarevenuegrowth"Synergy"100% onslide/mentioned"R&D""Low-hangingfruit""Stakeholders"Rob iswearing asweater"Shareholders"Rob takesa questionfromWexford"Movetheneedle"31-40% onslide/mentionedWe missedAOP forthe quarterRob iswearinga tie"Metrics"TArevenuedeclineA&GrevenuegrowthDan Rushtakes aquestion71-80% onslide/mentioned21-30% onslide/mentionedClincialrevenuegrowthRob takesa questionfrom NewCastle"Spectacular""Development"CherylKennedytakes aquestionMerger oracquisitionannounced81-90% onslide/mentionedMSDivision =highestearner"Fantastic"said morethan oncein a row91-100% onslide/mentioned"Clinical"61-70% onslide/mentionedIndustrialrevenuedecline"Leverage""Return onInvestment""MassSpectrometry""Logistics""Thinkoutsidethe box""Molecule""Growthmindset"Pharmarevenuedeclined

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
  1. Competetor name mentioned
  2. TA revenue growth
  3. "Science"
  4. Service = highest earner
  5. A&G revenue decline
  6. 0-10% on slide/mentioned
  7. "Impact"
  8. "Strategic"
  9. "Deep Dive"
  10. "Patients"
  11. "Circle Back"
  12. Amol Chaubal takes a question
  13. "Objective(s)"
  14. "Protein"
  15. "Pivot"
  16. Rob takes a question from Milford
  17. Kristen Garvey takes a question
  18. 51-60% on slide/mentioned
  19. Rob takes a question from someone online
  20. Chemistry = highest earner
  21. Andrew Ward takes a question
  22. "QC" or "Quality Control"
  23. 41-50% on slide/mentioned
  24. "Chromatography"
  25. Guest Speaker
  26. "Misson Statement"
  27. "Data Driven"
  28. We exceeded AOP for the quarter
  29. Rob pulls someone onstage to speak
  30. Christos Ross takes a question
  31. Technical Issues
  32. "Touch Base"
  33. "Pain Point"
  34. Clincal revenue decline
  35. "Empower"
  36. *New Product Announcement*
  37. Rob is wearing a jacket
  38. Rob takes a question from Wilmslow
  39. LC Division = highest earner
  40. "Culture" or "Company Culture"
  41. Industrial revenue growth
  42. "Genetic"
  43. "Customers"
  44. Rob takes a question from Manchester
  45. "Integrate"
  46. 11-20% on slide/mentioned
  47. Pharma revenue growth
  48. "Synergy"
  49. 100% on slide/mentioned
  50. "R&D"
  51. "Low-hanging fruit"
  52. "Stakeholders"
  53. Rob is wearing a sweater
  54. "Shareholders"
  55. Rob takes a question from Wexford
  56. "Move the needle"
  57. 31-40% on slide/mentioned
  58. We missed AOP for the quarter
  59. Rob is wearing a tie
  60. "Metrics"
  61. TA revenue decline
  62. A&G revenue growth
  63. Dan Rush takes a question
  64. 71-80% on slide/mentioned
  65. 21-30% on slide/mentioned
  66. Clincial revenue growth
  67. Rob takes a question from New Castle
  68. "Spectacular"
  69. "Development"
  70. Cheryl Kennedy takes a question
  71. Merger or acquisition announced
  72. 81-90% on slide/mentioned
  73. MS Division = highest earner
  74. "Fantastic" said more than once in a row
  75. 91-100% on slide/mentioned
  76. "Clinical"
  77. 61-70% on slide/mentioned
  78. Industrial revenue decline
  79. "Leverage"
  80. "Return on Investment"
  81. "Mass Spectrometry"
  82. "Logistics"
  83. "Think outside the box"
  84. "Molecule"
  85. "Growth mindset"
  86. Pharma revenue declined